全文获取类型
收费全文 | 852篇 |
免费 | 41篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 14篇 |
妇产科学 | 37篇 |
基础医学 | 193篇 |
口腔科学 | 18篇 |
临床医学 | 60篇 |
内科学 | 170篇 |
皮肤病学 | 7篇 |
神经病学 | 55篇 |
特种医学 | 24篇 |
外科学 | 94篇 |
综合类 | 5篇 |
预防医学 | 32篇 |
眼科学 | 16篇 |
药学 | 72篇 |
中国医学 | 14篇 |
肿瘤学 | 80篇 |
出版年
2023年 | 4篇 |
2022年 | 8篇 |
2021年 | 22篇 |
2020年 | 8篇 |
2019年 | 17篇 |
2018年 | 12篇 |
2017年 | 15篇 |
2016年 | 17篇 |
2015年 | 21篇 |
2014年 | 33篇 |
2013年 | 46篇 |
2012年 | 53篇 |
2011年 | 51篇 |
2010年 | 27篇 |
2009年 | 41篇 |
2008年 | 49篇 |
2007年 | 41篇 |
2006年 | 53篇 |
2005年 | 37篇 |
2004年 | 44篇 |
2003年 | 29篇 |
2002年 | 38篇 |
2001年 | 13篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1998年 | 15篇 |
1997年 | 8篇 |
1996年 | 4篇 |
1994年 | 6篇 |
1993年 | 4篇 |
1992年 | 12篇 |
1991年 | 11篇 |
1990年 | 12篇 |
1989年 | 12篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1976年 | 3篇 |
1975年 | 6篇 |
1973年 | 3篇 |
1968年 | 3篇 |
1967年 | 3篇 |
排序方式: 共有897条查询结果,搜索用时 15 毫秒
1.
Lara Feulner Hamed S. Najafabadi Simon Tanguay Janusz Rak Yasser Riazalhosseini 《Urologic oncology》2019,37(2):166-175
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献2.
Up to date 2 species of Mallophaga have been reported from birds in Iran. Further studies in Tehran area showed that the wild birds harbour more lice. The following species of Mallophage are reported for the first time from birds in Iran. Anaticola crassicornis from Anas clypeata, Laemobothrion maximum from Falco tinnunculus Laemobothrion sp. from Aquila chrysaetos Alcedoecus annulatus from Alcedo athis, Colpocephalum pectinatum and Strigiphilus sp. from Streptopelia turtur, Amrysidea fulvomaculata from Coturnix coturnix, philopterus picae from pica pica, Philopterus ocellatus and Colpocephalum pectinatum from Athene noctua, Philopterus sp. from Turdus ruficollis, Upupicola upupae from Upupa epops, Amyrsidea hexapilosus from Phasianus colchicus, Colpocephalum sp. from Falco cherrug. 相似文献
3.
Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season 总被引:4,自引:0,他引:4
Gabrielsson S Söderlund A Paulie S van der Pouw Kraan TC Troye-Blomberg M Rak S 《Allergy》2001,56(4):293-300
BACKGROUND: Specific allergen immunotherapy (SIT) is effective for treatment of IgE-mediated diseases: however, the mechanisms of action still remain unclear. Earlier, we showed that IL-4 and IL-13 are produced in response to specific allergens. The aim of this study was to investigate whether these cytokine responses were affected by allergen SIT, and, furthermore, to evaluate the effect of SIT on allergen-specific IgE and IgG4 levels. METHODS: Blood samples from pollen-sensitized individuals were collected before the pollen season (before treatment) and during the pollen season (after SIT or placebo treatment). Peripheral blood mononuclear cells were activated in vitro with allergens and the numbers of IL-4-, IL-13-, IL-10-, and IFN-gamma-producing cells were determined by ELISPOT. Serum levels of allergen-specific IgE and IgG4 were measured by RAST and ELISA, respectively. RESULTS: The numbers of IL-4- and IL-13-producing cells were shown to be increased in the placebo group during the pollen season, an increment which was absent in patients receiving allergen SIT. We found an increase in allergen-specific IgG4 in the SIT-treated individuals, but not in the placebo group. Both groups displayed elevated specific IgE levels during the pollen season. CONCLUSIONS: Taken together, our data show a downregulation of IL-4- and IL-13-producing cells in peripheral blood after SIT, suggesting induction of nonresponsiveness/tolerance or a redistribution of these cells. Furthermore, we demonstrate that SIT acts on antibody production by increasing the specific IgG4 levels. 相似文献
4.
Sabina Rak MD PhD Anette Bjrnson MSc Lena Hkanson MSc PhD Sverre Srenson MD PhD Per Venge MD PhD 《The Journal of allergy and clinical immunology》1991,88(6):878-888
Two groups of birch pollen--allergic patients with seasonal rhinoconjunctivitis and asthma were followed during two consecutive birch-pollen seasons, one group, N = 10, during a season with high pollen load, and one group, N = 15, during a season of low pollen load. Half the patients were treated with immunotherapy (IT) for 3 and 4 years, respectively. The other half of the patients served as control group (non-IT). Bronchoalveolar lavage (BAL) was performed once before each season and once during the pollen season. Eosinophil (EOS) numbers in BAL were increased (p less than 0.01) during the season with high pollen load but not in the season with a low pollen load, and this increment was absent in the IT-treated group. Also, the EOS cationic protein levels were raised in the non-IT-treated group during the season with a high pollen load. The levels of EOS and neutrophil chemotactic activity were raised in BAL in both seasons in the non-IT-treated group compared with the IT-treated group (p less than 0.02, p less than 0.003, p less than 0.04, and p less than 0.005 in high- and low-load pollen season, respectively). Serum and BAL eosinophil chemotactic activity (ECA) were positively correlated (p less than 0.001). We conclude that there is an influx of active EOSs into the lung of pollen-allergic patients with asthma during a pollen season, which may be abrogated by IT. Furthermore, the generation of ECA appears to be an extremely sensitive marker of antigenic exposure, and the potent inhibition of the generation of ECA by IT may provide a clue as to the mechanism of this treatment. 相似文献
5.
Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs 总被引:1,自引:0,他引:1
J Rak H Ku?nierczyk L Strzada?a S K?osiewicz C Radzikowski 《Archivum immunologiae et therapiae experimentalis》1989,37(3-4):389-397
On the basis of biological characteristics of murine transplantable mammary adenocarcinoma 16/c, experimental conditions optimal for chemotherapeutic experiments were defined. Sensitivity of primary tumor and lung metastases to the treatment with drugs used in breast cancer therapy: cyclophosphamide, 5-fluorouracil and adriamycin was confirmed. These drugs were significantly more effective in combination than when administered as monotherapy. Antimetastatic but not antitumor effect of 5-fluorouracil could be potentiated by using albumin microspheres as a carrier. Usefulness of the tumor model system in experimental chemotherapy is discussed. 相似文献
6.
Rachel Rabin Yoel Hirsch Martin M. Johansson Joseph Ekstein David A. Zeevi Beth Keena Elaine H. Zackai John Pappas 《American journal of medical genetics. Part A》2019,179(10):2144-2151
Warsaw breakage syndrome (WABS), caused by bi‐allelic variants in the DDX11 gene, is a rare cohesinopathy characterized by pre‐ and postnatal growth retardation, microcephaly, intellectual disability, facial dysmorphia, and sensorineural hearing loss due to cochlear hypoplasia. The DDX11 gene codes for an iron–sulfur DNA helicase in the Superfamily 2 helicases and plays an important role in genomic stability and maintenance. Fourteen individuals with WABS have been previously reported in the medical literature. Affected individuals have been of various ethnic backgrounds with different pathogenic variants. We report two unrelated individuals of Ashkenazi Jewish descent affected with WABS, who are homozygous for the c.1763‐1G>C variant in the DDX11 gene. Their phenotype is consistent with previously reported individuals. RNA studies showed that this variant causes an alternative splice acceptor site leading to a frameshift in the open reading frame. Carrier screening of the c.1763‐1G>C variant in the Jewish population revealed a high carrier frequency of 1 in 68 in the Ashkenazi Jewish population. Due to the high carrier frequency and the low number of affected individuals, we hypothesize a high rate of miscarriage of homozygous fetuses and/or subfertility for carrier couples. If the carrier frequency is reproducible in additional Ashkenazi Jewish populations, we suggest including DDX11 to Ashkenazi Jewish carrier screening panels. 相似文献
7.
Plewako H Arvidsson M Petruson K Oancea I Holmberg K Adelroth E Gustafsson H Sandström T Rak S 《The Journal of allergy and clinical immunology》2002,110(1):68-71
BACKGROUND: In sensitized patients, coupling between IgE and FcepsilonRI receptors on mast cells leads to release of proinflammatory mediators and a subsequent influx of inflammatory cells to the affected organ. Omalizumab (Xolair; formerly rhuMAb-E25) binds to circulating IgE, thus preventing induction of the allergic process. OBJECTIVE: We investigated the effect of treatment with omalizumab on seasonal allergic rhinitis and related changes in inflammatory cell numbers in nasal biopsy specimens. METHODS: Patients were randomized to treatment with omalizumab or placebo before the pollen season; the treatment was started and continued during season. Symptoms and use of medication were recorded, and blood samples and nasal biopsy specimens were obtained before and during season. Immunocytochemistry was performed on biopsy sections through use of the following antibodies: anti-CD4, CD8 (T lymphocytes), EG2, and anti-eosinophil peroxidase (eosinophils), anti-tryptase (mast cells), human neutrophil lipocalin (neutrophils), and antibodies against IgE and FcepsilonRI. RESULTS: During the season, blood eosinophils increased in placebo-treated patients but not in omalizumab-treated patients (P =.01); the difference between the treatment groups was significant (P =.04). Free IgE in serum decreased significantly (P =.0002) in omalizumab-treated patients but not in placebo-treated patients; the difference between the groups was significant (P =.0001). In nasal biopsy specimens, the number of eosinophil peroxidase-positive staining cells increased in the placebo-treated patients (P =.003) but not in the actively treated patients during the season; the difference between the groups was significant (P =.0001). The number of IgE(+) staining cells decreased significantly in the omalizumab group during the season in comparison with the placebo group (P =.04). CONCLUSION: The clinical benefit of treatment with omalizumab is associated with an anti-inflammatory effect on cellular markers in blood and nasal tissue. 相似文献
8.
Jan Höltge Linda Theron Richard G. Cowden Kaymarlin Govender Sally I. Maximo Jennifer S. Carranza Bhumika Kapoor Aakanksha Tomar Angelique van Rensburg Shuang Lu Hongwei Hu Valeria Cavioni Alessia Agliati Ilaria Grazzani Yoel Smedema Gunjanpreet Kaur Kingsley G. Hurlington Jackie Sanders Michael Ungar 《The Journal of adolescent health》2021,68(3):580-588
PurposeIn situations of adversity, young people draw on individual, relational, and contextual (community and cultural) resources to foster their resilience. Recent literature defines resilience as a capacity that is underpinned by a network of interrelated resources. Although empirical studies show evidence of the value of a network approach, little is known regarding how different country contexts influence which resources are most critical within a resource network and how resources interact for adolescent resilience.MethodsNetwork analysis was conducted with data from studies that had used the Child and Youth Resilience Measure. Regularized partial correlation networks of 17 resources were estimated for 14 countries (Botswana, Canada, China, Colombia, Equatorial Guinea, India, Indonesia, Italy, Jordan, New Zealand, the Philippines, Romania, South Africa, and Syrian refugees living in Jordan). The sample size was 18,914 (mean age = 15.70 years, 48.8% female).ResultsWe observed mostly positive associations between the resources of interest. The salience and strength of associations between resources varied by country. The most central resource across countries was having supportive caregivers during stressful times because this resource had the most and strongest positive associations with other resources.ConclusionsThis study gives first empirical evidence from multiple countries that an interplay of social–ecological resources (such as individual skills, peer, caregiver and community support, and educational aspirations and opportunities) matter for adolescent resilience. Across countries, caregiver support appears to be most central for adolescent resilience. Future resilience interventions might apply this network approach to identify important, contextually relevant resources that likely foster additional resources. 相似文献
9.
10.